Osteonecrosis of the Jaw in a Male Osteoporotic Patient Treated With Denosumab

Osteoporosis International - United Kingdom
doi 10.1007/s00198-013-2437-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Osteonecrosis of the Jaw in a Patient Treated With Denosumab and Temsirolimus

SAJ Case Reports
2017English

Surgical Therapy for Medication-Related Osteonecrosis of the Jaw in Osteoporotic Patients Treated With Antiresorptive Agents

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2020English

Denosumab: Prevention and Management of Hypocalcemia, Osteonecrosis of the Jaw and Atypical Fractures

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2016English

Osteonecrosis of the Jaw in a Patient Receiving Bisphosphonate Therapy

Oncology Nursing Forum
Oncology
2007English

A Case of Osteonecrosis of the Jaw in a Patient Receiving Sunitinib

Japanese Journal of Oral and Maxillofacial Surgery
2018English

Comment On: Medication-Related Osteonecrosis of the Jaw in Osteoporotic Patients: Prevention and Management

Singapore Medical Journal
Medicine
2019English

Microbial Population Changes in Patients With Medication-Related Osteonecrosis of the Jaw Treated With Systemic Antibiotics

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Nuclear MedicineRadiologyOral SurgeryImagingDentistryForensic MedicinePathologySurgery
2018English

Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients After Treatment With Zoledronic Acid or Denosumab: A Retrospective Cohort Study

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2015English

Medication-Related Osteonecrosis of the Jaw

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy